-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Insmed (INSM)
-
-
-
-
-
-
-
Insmed (INSM) Prices Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2028
-
-
-
-
-
-
-
Insmed to Present at Two September Conferences
-
-
-
-
-
-
-
Insmed Provides Update on ARIKAYCE® (amikacin liposome inhalation suspension) U.S. Launch
-
20,596 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

